These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16575207)

  • 1. Enhancement of DNA vaccine potency by sandwiching antigen-coding gene between secondary lymphoid tissue chemokine (SLC) and IgG Fc fragment genes.
    Liu R; Zhou C; Wang D; Ma W; Lin C; Wang Y; Liang X; Li J; Guo S; Wang Y; Zhang Y; Zhang S
    Cancer Biol Ther; 2006 Apr; 5(4):427-34. PubMed ID: 16575207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tumor associated antigen gene-modified tumor cell and blockade of B7-H1.
    Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
    J Clin Immunol; 2007 Jan; 27(1):117-30. PubMed ID: 17180470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor effect against human telomerase reverse transcriptase (hTERT) by vaccination with chemotactic-hTERT gene-modified tumor cell and the combination with anti-4-1BB monoclonal antibodies.
    Lin X; Zhou C; Wang S; Wang D; Ma W; Liang X; Lin C; Wang Z; Li J; Guo S; Zhang Y; Zhang S
    Int J Cancer; 2006 Oct; 119(8):1886-96. PubMed ID: 16708388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Moeini S; Saeidi M; Fotouhi F; Mondanizadeh M; Shirian S; Mohebi A; Gorji A; Ghaemi A
    Arch Virol; 2017 Feb; 162(2):333-346. PubMed ID: 27699512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.
    Kirk CJ; Hartigan-O'Connor D; Nickoloff BJ; Chamberlain JS; Giedlin M; Aukerman L; Mule JJ
    Cancer Res; 2001 Mar; 61(5):2062-70. PubMed ID: 11280767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Cheng WF; Hung CF; Hsu KF; Chai CY; He L; Ling M; Slater LA; Roden RB; Wu TC
    Hum Gene Ther; 2001 Feb; 12(3):235-52. PubMed ID: 11177561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
    Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
    J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective and therapeutic antitumour immunity using a novel tumour-associated antigen-specific DNA vaccine.
    Sun W; Qian H; Zhang X; Zhou C; Liang X; Wang D; Fu M; Ma W; Zhang S; Lin C
    Immunol Cell Biol; 2006 Oct; 84(5):440-7. PubMed ID: 16942487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
    Eo SK; Lee S; Kumaraguru U; Rouse BT
    Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
    Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
    Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.
    Hung CF; Hsu KF; Cheng WF; Chai CY; He L; Ling M; Wu TC
    Cancer Res; 2001 Feb; 61(3):1080-8. PubMed ID: 11221836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
    Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel chemotactic-antigen DNA vaccine against cancer.
    Zhang S; Zhang Y
    Future Oncol; 2008 Apr; 4(2):299-303. PubMed ID: 18407741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.
    Hauser H; Shen L; Gu QL; Krueger S; Chen SY
    Gene Ther; 2004 Jun; 11(11):924-32. PubMed ID: 15085173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation.
    Itakura M; Tokuda A; Kimura H; Nagai S; Yoneyama H; Onai N; Ishikawa S; Kuriyama T; Matsushima K
    J Immunol; 2001 Feb; 166(3):2071-9. PubMed ID: 11160258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting dendritic cells to enhance DNA vaccine potency.
    You Z; Huang X; Hester J; Toh HC; Chen SY
    Cancer Res; 2001 May; 61(9):3704-11. PubMed ID: 11325842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral administration of secondary lymphoid chemokine and unmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotide synergistically inhibits tumor growth in vivo.
    Oh SM; Oh K; Lee DS
    J Korean Med Sci; 2011 Oct; 26(10):1270-6. PubMed ID: 22022177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination.
    Matsuyoshi H; Senju S; Hirata S; Yoshitake Y; Uemura Y; Nishimura Y
    J Immunol; 2004 Jan; 172(2):776-86. PubMed ID: 14707047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.